secwatch.observer — SEC 8-K summary
======================================

Issuer:     Inmune Bio, Inc. (INMB)
CIK:        0001711754
Form:       8-K
Filed at:   2024-11-13T23:59:59+00:00
Accession:  0001213900-24-097090
Event type: other
Sentiment:  neutral
Materiality: 0.20
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

INmune Bio releases new investor presentation; no financial updates in filing
-----------------------------------------------------------------------------

- Company furnished a slide deck for use in investor presentations (Exhibit 99.1).
- Deck posted on company website under 'Investors – Corporate Presentation' section.
- Filing contains no new financial results, clinical data, or guidance changes.
- Presentation includes forward-looking statements; no material events disclosed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1711754/000121390024097090/0001213900-24-097090-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1711754/000121390024097090/ea0220968-8k_inmunebio.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-097090

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer